Geode Capital · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
Geode Capital Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 6.4M | $2.4B | — |
| 2024Q2 | 7.6M | $3.0B | +23.0% |
| 2024Q3 | 7.2M | $2.8B | -6.7% |
| 2024Q4 | 6.9M | $2.3B | -16.6% |
| 2025Q1 | 7.1M | $2.8B | +21.1% |
| 2025Q2 | 7.5M | $2.7B | -5.3% |
| 2025Q3 | 7.7M | $2.4B | -11.6% |
| 2025Q4 | 7.8M | $2.7B | +15.4% |
| 2026Q1 | 7.9M | $2.8B | +0.6% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F